We are live on ! Find out more
Aviva

Aviva Portfolio holdings

AUM $59.6B
1-Year Est. Return 28.44%
This Fund
S&P 500
This Quarter Est. Return
+1.98%
1 Year Est. Return
+28.44%
3 Year Est. Return
+95.57%
5 Year Est. Return
+123.24%
10 Year Est. Return
+442.53%
AUM
$14.8B
AUM Growth
+$198M
Cap. Flow
+$49.3M
Cap. Flow %
0.33%
Top 10 Hldgs %
21.47%
Holding
817
New
24
Increased
116
Reduced
615
Closed
23

Top Buys

Rank Stock Value
1
CMCSA icon
Comcast
CMCSA
+$75.5M
2
TT icon
Trane Technologies
TT
+$47M
3
MSFT icon
Microsoft
MSFT
+$46M
4
AAPL icon
Apple
AAPL
+$43.4M
5
ALLE icon
Allegion
ALLE
+$38M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$46.6M
2
MU icon
Micron Technology
MU
+$32.5M
3
BABA icon
Alibaba
BABA
+$30.2M
4
BA icon
Boeing
BA
+$26.2M
5
NFLX icon
Netflix
NFLX
+$23.8M

Sector Composition

Rank Sector Weight
1 Technology 17.39%
2 Financials 16.7%
3 Healthcare 12.96%
4 Consumer Discretionary 10.39%
5 Communication Services 10.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BN icon
176
Brookfield
BN
$102B
$15.9M 0.11%
837,342
-38,753
-4% -$702K
AVB icon
177
AvalonBay Communities
AVB
$27.5B
$15.8M 0.11%
73,460
-5,471
-7% -$1.14M
ELV icon
178
Elevance Health
ELV
$81.6B
$15.8M 0.11%
65,677
-31,415
-32% -$8.61M
ILMN icon
179
Illumina
ILMN
$29.4B
$15.8M 0.11%
53,284
-2,404
-4% -$709K
EOG icon
180
EOG Resources
EOG
$77.6B
$15.7M 0.11%
211,224
-2,295
-1% -$186K
VRTX icon
181
Vertex Pharmaceuticals
VRTX
$123B
$15.3M 0.1%
90,593
-3,548
-4% -$628K
BIIB icon
182
Biogen
BIIB
$30.9B
$15.1M 0.1%
64,989
-7,132
-10% -$1.66M
COF icon
183
Capital One
COF
$128B
$15M 0.1%
164,935
-7,054
-4% -$634K
HDB icon
184
HDFC Bank
HDB
$123B
$15M 0.1%
524,228
+41,012
+8% +$1.17M
WBA
185
DELISTED
Walgreens Boots Alliance
WBA
$15M 0.1%
270,318
-19,701
-7% -$1.06M
BAX icon
186
Baxter International
BAX
$12.8B
$14.9M 0.1%
170,432
-10,688
-6% -$912K
DG icon
187
Dollar General
DG
$28.3B
$14.5M 0.1%
91,512
-5,209
-5% -$753K
ADI icon
188
Analog Devices
ADI
$173B
$14.5M 0.1%
129,766
-6,222
-5% -$705K
EMR icon
189
Emerson Electric
EMR
$81.7B
$14.5M 0.1%
216,132
-9,838
-4% -$618K
TFC icon
190
Truist Financial
TFC
$63.8B
$14.4M 0.1%
269,871
-13,365
-5% -$662K
MPC icon
191
Marathon Petroleum
MPC
$90.1B
$14.3M 0.1%
235,585
-14,556
-6% -$767K
SRE icon
192
Sempra
SRE
$58.1B
$14.3M 0.1%
193,734
-9,186
-5% -$643K
EMB icon
193
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
$14.9B
$14.3M 0.1%
125,934
KMI icon
194
Kinder Morgan
KMI
$70.9B
$14.2M 0.1%
689,285
-32,175
-4% -$661K
ATVI
195
DELISTED
Activision Blizzard
ATVI
$14.2M 0.1%
267,674
-12,301
-4% -$613K
BSX icon
196
Boston Scientific
BSX
$68.5B
$14.1M 0.1%
346,819
-162,551
-32% -$6.89M
OXY icon
197
Occidental Petroleum
OXY
$55.7B
$14.1M 0.1%
315,975
+38,188
+14% +$1.81M
ROST icon
198
Ross Stores
ROST
$80.8B
$13.9M 0.09%
126,890
-6,337
-5% -$668K
NDAQ icon
199
Nasdaq
NDAQ
$53.4B
$13.9M 0.09%
420,519
+11,661
+3% +$388K
TRV icon
200
Travelers Companies
TRV
$80.9B
$13.7M 0.09%
92,220
-5,444
-6% -$809K

Similar funds

Aviva's Q3 2019 Portfolio in Review

As of Q3 2019, Aviva held 817 positions worth $14.8B, up 1.4% from $14.6B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Aviva's Q3 2019 filing shows 24 new, 116 increased, 615 reduced and 23 closed positions. Its largest new stake was Lennox International: 50,194 shares worth $12.2M. The largest sale was Pfizer, an estimated $46.6M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.

  • Aviva's largest Q3 2019 buy was Lennox International: 50,194 shares worth $12.2M.
  • Aviva added most to Comcast in Q3 2019, an estimated $75.5M increase.
  • Aviva's biggest Q3 2019 reduction was Pfizer, cutting an estimated $46.6M.
  • Aviva fully exited Worldpay, Inc. in Q3 2019, selling an estimated $13.8M.
  • Aviva's ten largest holdings make up 21% of its $14.8B portfolio in Q3 2019.
  • Aviva opened 24 new positions and closed 23 in Q3 2019.
  • Aviva's portfolio value rose 1.4% quarter-over-quarter to $14.8B.

Based on Aviva's 13F filing for Q3 2019, filed 12 Nov 2019.